Company intelligence / Profile preview

Choix

San Francisco, California, United Stateschoixhome.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Choix was a pioneering telehealth clinic that provided asynchronous abortion care and other sexual/reproductive health services to over 8,000 patients across six states. It was recognized for high patient satisfaction (>98% would recommend), innovation during crisis periods, and expanding access to advance provision of abortion pills. The company ceased virtual operations on October 31, 2023 due to political challenges but referred patients to carafem for ongoing care.

Therapeutic areas: Women's Health
Modalities: Small molecule (mifepristone and misoprostol, as abortion medications)Telemedicine service delivery (non-pharmacological therapy)
Industry: Non-Academic Healthcare

Partnerships

carafem (referral partnership after closure)

Beyond the preview

Go deeper on Choix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Choix.

Explore the full profile